Inactive Instrument

Other languages KaloBios Pharmaceuticals Inc Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 12	Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc.	CI
Mar. 08	Final DIP Financing Approved for Humanigen, Inc.	CI

19 treatment developer Humanigen files for Chapter 11 bankruptcy	Jan. 04
Humanigen, Inc. Filed for Bankruptcy	Jan. 03
Xspray Pharma Names Chief Commercial Officer	23-09-15
Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer	23-09-14
Sector Update: Health Care Stocks Steady in Late Afternoon Trading	23-07-25
Sector Update: Health Care Stocks Steady Tuesday Afternoon	23-07-25
Sector Update: Health Care	23-07-25
Humanigen Issues 'Going Concern' Warning; Shares Hit 52-Week Low	23-07-25
Humanigen, Inc. Announces Board Changes	23-07-25
Humanigen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Humanigen, Inc. Auditor Raises 'Going Concern' Doubt	23-03-29
Humanigen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Opthea Appoints CFO	22-10-24
DBV Technologies : nouveau président du comité d'audit	22-10-04
Humanigen, Inc. Announces Executive Changes	22-09-29
Humanigen Chief Medical Officer Adrian Kilcoyne Resigns	22-09-02
Humanigen, Inc. Announces Resignation Adrian Kilcoyne as Chief Medical Officer, Effective September 28, 2022	22-09-02
Humanigen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12
Humanigen Says NIH Study of COVID-19 Drug Fails to Reach Primary Endpoint; Shares Fall	22-07-13
Sector Update: Health Care Stocks Slip Pre-Bell Wednesday	22-07-13

No results for this search